Media, page-50

I have no idea why it’s taken so long, it’s a bit sus. Did they have IMP761 as a back up strategy if Efti stumbled? 18-24 months is sufficiently far away that it could be quietly sidelined especially if Efti carries on the way it is. If Efti stumbles(v unlikely) they can bring the focus back on it and get it moving.
They also have the Lag3 small molecule research going but who knows how far from the clinic that is… five ten fifteen years? Take your pick

But the main focus here is Efti and the progressing and expanding trials. Autoimmune will be blurred vision for another 18 months or so